We are happy to present the winners of the American Neuromuscular Foundation's (ANF) 2024 Investigator Grant Award. Liubov Gushchina, PhD, received the prize for...
The FDA has granted IPS HEART Orphan Drug Designation (ODD) for GIVI-MPCs because of its exceptional capacity to produce new muscle with full length...
A medication for DMD cardiomyopathy, pemziviptadil is used once a week and is based on ImmunForge's ELP Platform (Elastin Like Polypeptide Platform), a long-acting...
Dyne Therapeutics announced positive clinical data for its therapies DYNE-101 and DYNE-251 during an investor event on January 10, 2025. DYNE-101 for myotonic dystrophy...